BCOR and myelodysplastic syndrome: BCOR mutations are detected in less than 5% of patients with MDS and are typically frameshift insertions or deletions, or stopgain or non-sense mutations, causing a suppression of function of the BCOR protein in hematopoietic cells [70,71].